C12N 2710/14111
Nucleopolyhedrovirus
Official title: Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
C12N2710/14111 (Nucleopolyhedrovirus) appears on 562 US grants and 567 published applications in this corpus.
Search patents in C12N- Granted patents
- 562
- Published applications
- 567
- Assignees
- 389
- Inventors
- 1,336
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 8 | 0 |
| 1992 | 11 | 0 |
| 1993 | 12 | 0 |
| 1994 | 14 | 0 |
| 1995 | 10 | 0 |
| 1996 | 10 | 0 |
| 1997 | 25 | 0 |
| 1998 | 30 | 0 |
| 1999 | 32 | 0 |
| 2000 | 18 | 0 |
| 2001 | 32 | 1 |
| 2002 | 20 | 21 |
| 2003 | 10 | 15 |
| 2004 | 18 | 36 |
| 2005 | 11 | 30 |
| 2006 | 17 | 22 |
| 2007 | 16 | 20 |
| 2008 | 19 | 26 |
| 2009 | 9 | 37 |
| 2010 | 15 | 34 |
| 2011 | 19 | 27 |
| 2012 | 9 | 23 |
| 2013 | 13 | 25 |
| 2014 | 17 | 12 |
| 2015 | 18 | 25 |
| 2016 | 13 | 14 |
| 2017 | 16 | 15 |
| 2018 | 17 | 20 |
| 2019 | 20 | 21 |
| 2020 | 18 | 23 |
| 2021 | 7 | 23 |
| 2022 | 15 | 23 |
| 2023 | 9 | 22 |
| 2024 | 6 | 27 |
| 2025 | 14 | 11 |
| 2026 | 8 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/14141Use of virus, viral particle or viral elements as a vectorIndexing code519
- C12N 2710/14122New viral proteins or individual genes, new structural or functional aspects ofIndexing code55
- C12N 2710/14151Methods of production or purification of viral materialIndexing code30
- C12N 2710/14121Viruses as suchIndexing code23
- C12N 2710/14161Methods of inactivation or attenuationIndexing code10
- C12N 2710/14171Demonstrated in vivo effectIndexing code6
- C12N 2710/14131Uses of virus other than therapeutic or vaccineIndexing code4
- C12N 2710/14132Use of virus as therapeutic agent, other than vaccineIndexing code4
Recent patents
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- DNA impurities in a composition comprising a parvoviral virion7 Jul 2026US 12,674,211 B2uniQure IP B.V.
- SmartBac baculovirus expression system and application thereof9 Jun 2026US 12,649,931 B2Institute of Biophysics, Chinese Pie Academy of Sciences
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals2 Jun 2026US 12,642,831 B2MangoGen Pharma, Inc.
- AAV6 variants12 May 2026US 12,624,367 B2University of Florida Research Foundation, Inc.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
- Modified g protein coupled receptor and use thereof23 Jul 2026US 2026/0209311 A1Alphelix Biotech Co., Ltd.
- Methods and compositions for enriching circulating cell-free nucleic acids in a biological sample25 Jun 2026US 2026/0176705 A1Centre for Novostics
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
Most cited
By later US patents
- Insect control agent288US 6,326,193 B1Cambria Biosciences, LLC · 2001
- Method for producing a recombinant baculovirus expression vector209US 4,745,051 AThe Texas A&M University System · 1988
- Baculovirus expression system and method for high throughput expression of genetic material170US 6,225,060 B1Onyx Pharmaceuticals, Inc. · 2001
- Method for producing a recombinant baculovirus expression vector164US 4,879,236 AThe Texas A&M University System · 1989
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999